Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations Sarkar S; Rubinsztein DCAutophagy 2006[Apr]; 2 (2): 132-4We recently showed that lithium induces autophagy via inositol monophosphatase (IMPase) inhibition, leading to free inositol depletion and reduced myo-inositol-1,4, 5-triphosphate (IP3) levels. This represents a novel way of regulating mammalian autophagy, independent of the mammalian target of rapamycin (mTOR). Induction of autophagy by lithium led to enhanced clearance of autophagy substrates, like mutant huntingtin fragments and mutant alpha-synucleins, associated with Huntington's disease (HD) and some autosomal dominant forms of Parkinson's disease (PD), respectively. Similar effects were observed with a specific IMPase inhibitor and mood-stabilizing drugs that decrease inositol levels. This may represent a new therapeutic strategy for upregulating autophagy in the treatment of neurodegenerative disorders, where the mutant protein is an autophagy substrate. In this Addendum, we review these findings, and some of the speculative possibilities they raise.|Autophagy/drug effects/*physiology[MESH]|Diphosphonates/pharmacology[MESH]|Huntingtin Protein[MESH]|Inositol/*metabolism[MESH]|Lithium Compounds/therapeutic use[MESH]|Mutation[MESH]|Nerve Tissue Proteins/genetics/metabolism[MESH]|Neurodegenerative Diseases/*drug therapy/metabolism[MESH]|Nuclear Proteins/genetics/metabolism[MESH]|Phosphoric Monoester Hydrolases/antagonists & inhibitors/*metabolism[MESH]|Signal Transduction[MESH]|alpha-Synuclein/genetics/metabolism[MESH] |